Enjoy complimentary customisation on priority with our Enterprise License!
The global large molecule injectable drugs market size is estimated to grow by USD 191.45 billion at a CAGR of 7.86% between 2022 and 2027.
Emerging economies like India and Brazil are witnessing increasing detection of chronic diseases such as cancer, diabetes, cardiovascular diseases, and autoimmune disorders. For effective treatment and management of such conditions, large-molecule injectable drugs are vital. With increasing population and lifestyle changes there will be increasing demand for advanced therapies and large-molecule injectable drugs. Additionally, several emerging economies are increasing healthcare expenditure, especially with regard to the establishment of specialized hospitals and healthcare centers. With improving healthcare infrastructure, the demand for large-molecule injectable drugs is also predicted to rise. Increasing awareness about the availability and effectiveness of these drugs is also contributing to market growth. These improved healthcare facilities enable the administration and management of large-molecule injectable drugs which will have a positive impact on the market during the forecast period.
To learn more about this report, Request Free Sample
Hospital pharmacies segment
The market share growth by the hospital pharmacies segment will be significant during the forecast period. Hospital pharmacies are essential for managing and dispensing large-molecule injectable drugs and ensuring safe and effective use. Moreover, the increasing demand for personalized therapies in turn will increase the demand for biologics injectable drugs by this segment. This will also result in the growing importance of efficient inventory management, storage, and handling practices within hospital pharmacies to meet the needs of patients and healthcare providers.
Get a glance at the market contribution of various segments View a PDF Sample
The hospital pharmacies segment was valued at USD 126.00 billion in 2017. The treatment and management of various chronic diseases like cancer and rare genetic disorders have been revolutionized by biopharmaceutical injectable drugs. With the rising number of biologics injectable drugs being developed and approved for clinical use, there is expected to be substantial market growth by this segment during the forecast period.
Intravenous injection segment
The intravenous (IV) injection segment includes the direct delivery of medication into the bloodstream. This ensures that the distribution of the required medication to the target tissues or cells is rapid and efficient. This approach limits the possibility of adverse effects by reducing exposure of the medication to non-target tissues. Furthermore, such targeted delivery of medication is vital in personalized therapies that use large-molecule drugs like monoclonal antibodies. Moreover, the increasing demand for personalized therapies will also boost segment growth during the forecast period
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The North American region is the largest regional market due to the presence of well-developed healthcare systems such as hospitals, clinics, and specialized treatment centers that possess advanced infrastructure. They increasingly administer and manage large-molecule injectable drugs for the treatment of various chronic diseases like cancer, autoimmune disorders, and diabetes that require targeted therapy.
Moreover, this region has exceptional R&D infrastructure in the pharmaceutical industry, especially in biotechnology and large-molecule drugs. Some of the major global biopharmaceutical companies originate from North America and they conduct research and develop novel large-molecule injectable drugs. Hence such factors will fuel regional market growth during the forecast period.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Boehringer Ingelheim International GmbH - The company offers large molecule injectable drugs such as HArmonyCa, JUVEDERM VOLBELLA XC, and JUVEDERM VOLUMA XC.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the trends, and challenges.
The increased focus on precision medicine and personalized therapies is a key trend in the market. The increasing prevalence of diseases that require targeted and effective treatments is accountable for the increasing demand for large-molecule injectable drugs. Some health conditions like cancer, autoimmune disorders, rheumatoid arthritis, and rare genetic diseases require treatment that manages the disease symptoms. Biologics injectables help to interact with specific molecular targets that play a role in disease processes, offering targeted therapy. They often demonstrate superior efficacy and safety profiles compared to conventional small-molecule drugs.
Moreover, they have higher efficacy and enhanced safety profiles in comparison to small-molecule drugs. They are vital in -precision medicine which requires treatments according to an individual's specific genetic profile or disease characteristics. Moreover, the increasing demand for personalized therapies due to a greater number of genomic testing and targeted treatments is resulting in the growing demand for biopharmaceutical injectable drugs. Hence such factors are expected to propel market growth during the forecast period.
The high development and manufacturing costs are challenging market growth. The development and production of biopharmaceutical injectables are costly due to the high degree of complexity of the manufacturing process, and the requirement for sophisticated facilities and equipment. This may affect their affordability which will severely impact the profitability of companies in the market. Conducting clinical trials with a sufficient number of patients, ensuring safety and efficacy, and meeting regulatory requirements are costly endeavors.
Moreover, conducting clinical trials to ensure compliance with relevant regulations requires further costs to ensure safety and efficacy. These trials are conducted in controlled environments with the usage of advanced technologies for monitoring and control. Significant costs are also incurred for the acquisition of and maintenance of these facilities and equipment which will also pose a challenge to market growth during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Market Analyst Overview
The Large Molecule Injectable Drugs Market is analyzed through various strategic frameworks, including Porter's 5 Forces Framework and SWOT analysis. Value chain analysis provides insights into the intricate processes involved in manufacturing and distribution. Pricing analysis helps stakeholders understand market dynamics and competitive positioning. Competitive rivalry is intense, driven by the constant pursuit of market share and innovation. Threats of new entry and substitution are significant considerations, while supplier and buyer bargaining power influence market dynamics. Winning imperatives include research and development, regulatory compliance, and market penetration strategies. The current focus of the market is on expanding product portfolios, enhancing manufacturing capabilities, and improving distribution networks to meet the growing demand for large molecule injectable drugs.
Large Molecule Injectable Drugs Market Scope |
|
Report Coverage |
Details |
Page number |
158 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.86% |
Market growth 2023-2027 |
USD 191.45 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
7.62 |
Regional analysis |
North America, Asia, Europe, and the Rest of the World (ROW) |
Performing market contribution |
North America at 45% |
Key countries |
US, Canada, China, Japan, and Germany |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Co. Ltd., AbbVie Inc., Amgen Inc., AstraZeneca Plc, Baxter International Inc., Biogen Inc., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Medtronic Plc, Merck and Co. Inc., Novartis AG, Novo Nordisk AS, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd. |
Market dynamics |
Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.